Lipid–sugar particles for intracranial drug delivery: safety and biocompatibility

This publication has 13 references indexed in Scilit:

• Biocompatibility of lipid‐protein‐sugar particles containing bupivacaine in the epineurium
  Journal of Biomedical Materials Research, 2001
• Inapparent Hemodynamic Insufficiency Exacerbates Ischemic Damage in a Rat Microembolic Stroke Model
  Stroke, 2000
• Sciatic Nerve Blockade with Lipid-Protein-Sugar Particles Containing Bupivacaine
  Pharmaceutical Research, 2000
• The development of new brain tumor therapy utilizing the local and sustained delivery of chemotherapeutic agents from biodegradable polymers
  Cancer, 1999
• Large Porous Particles for Sustained Protection from Carbachol-Induced Bronchoconstriction in Guinea Pigs
  Pharmaceutical Research, 1999
• Attenuation of Delayed Neuronal Death after Mild Focal Ischemia in Mice by Inhibition of the Caspase Family
  Journal of Cerebral Blood Flow & Metabolism, 1998
• Transport and elimination of recombinant human NGF during long-term delivery to the brain
  Brain Research, 1996
• Serum‐free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus
  Journal of Neuroscience Research, 1995
• Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres
  Biomaterials, 1993
• Controlled release of dopamine from a polymeric brain implant: In vivo characterization
  Annals of Neurology, 1989